Search Results 761-770 of 16333 for pharmacogenetics
The purpose of this study is to evaluate the effectiveness of depemokimab 200 mg subcutaneous (SC) given every 6 months versus placebo in participants with ...
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...
Mayo Clinic Minute: Using AI to predict kidney failure in patients with polycystic kidney disease · New podcast: 'Rapid Genome Sequencing' featured image.
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
c. Cancer Biology and Translational Research: John A. Copland III · Cardiovascular Tissue Engineering Research: Leigh G. Griffiths · Cell and Molecular ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
sexually transmitted diseases ... The purpose of this research is to validate new testing methods for diagnosing patients with Treponema pallidum (syphilis). A ...
Latest stories · Lab-grown 'mini brains' help Mayo Clinic scientists shed light on therapeutic targets · Science Saturday: AI enables early identification, ...
Your Mayo Clinic care team ... Mayo Clinic's MGUS teams are led by specialists in blood disorders, known as hematologists. The team includes other specialists as ...
Plasma biomarker screening could improve accuracy, health equity in Alzheimer's disease diagnosis featured image · Mayo Clinic study reports genomic data ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.